Birdwatch Note
2023-08-01 14:39:55 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Ivermectin has no efficacy to treat COVID-19 based on randomized controlled trials. The studies that did show benefit for ivermectin were in vitro or observational in nature. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362 https://jamanetwork.com/journals/jama/fullarticle/2777389 https://www.nejm.org/doi/full/10.1056/NEJMoa2201662
Written by F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1686384846535569408
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1686386281063051265
- noteId - 1686386281063051265
- participantId -
- noteAuthorParticipantId - F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D Participant Details
- createdAtMillis - 1690900795605
- tweetId - 1686384846535569408
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ivermectin has no efficacy to treat COVID-19 based on randomized controlled trials. The studies that did show benefit for ivermectin were in vitro or observational in nature. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362 https://jamanetwork.com/journals/jama/fullarticle/2777389 https://www.nejm.org/doi/full/10.1056/NEJMoa2201662
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-08-01 14:39:55 UTC (1690900795605) |
1969-12-31 23:59:59 UTC (-1) |
2023-08-02 02:13:14 UTC (1690942394331) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-08-01 18:35:20 -0500 | Rating Details | |
2023-08-01 18:20:31 -0500 | Rating Details | |
2023-08-01 18:17:52 -0500 | Rating Details | |
2023-08-01 18:07:24 -0500 | Rating Details | |
2023-08-01 17:51:58 -0500 | Rating Details | |
2023-08-01 17:14:06 -0500 | Rating Details | |
2023-08-01 16:58:39 -0500 | Rating Details | |
2023-08-01 16:50:56 -0500 | Rating Details | |
2023-08-01 16:49:22 -0500 | Rating Details | |
2023-08-01 16:39:22 -0500 | Rating Details | |
2023-08-01 16:34:46 -0500 | Rating Details | |
2023-08-01 16:29:02 -0500 | Rating Details | |
2023-08-01 16:18:02 -0500 | Rating Details | |
2023-08-01 16:14:39 -0500 | Rating Details | |
2023-08-01 16:03:06 -0500 | Rating Details | |
2023-08-01 16:00:47 -0500 | Rating Details | |
2023-08-01 15:51:03 -0500 | Rating Details | |
2023-08-01 15:48:26 -0500 | Rating Details | |
2023-08-01 15:37:03 -0500 | Rating Details | |
2023-08-01 15:34:03 -0500 | Rating Details | |
2023-08-01 15:32:45 -0500 | Rating Details | |
2023-08-01 15:13:15 -0500 | Rating Details | |
2023-08-01 15:10:37 -0500 | Rating Details | |
2023-08-01 14:58:58 -0500 | Rating Details | |
2023-08-01 14:50:47 -0500 | Rating Details | |
2023-08-01 14:43:48 -0500 | Rating Details | |
2023-08-01 14:42:25 -0500 | Rating Details | |
2023-08-01 14:30:40 -0500 | Rating Details | |
2023-08-01 14:30:25 -0500 | Rating Details | |
2023-08-01 14:20:28 -0500 | Rating Details | |
2023-08-01 14:17:40 -0500 | Rating Details | |
2023-08-01 13:21:15 -0500 | Rating Details | |
2023-08-01 12:58:40 -0500 | Rating Details | |
2023-08-01 12:39:44 -0500 | Rating Details | |
2023-08-01 11:50:11 -0500 | Rating Details | |
2023-08-01 11:30:29 -0500 | Rating Details | |
2023-08-01 11:05:06 -0500 | Rating Details | |
2023-08-01 10:51:06 -0500 | Rating Details | |
2023-08-01 10:42:29 -0500 | Rating Details | |
2023-08-01 10:37:05 -0500 | Rating Details | |
2023-08-01 10:29:02 -0500 | Rating Details | |
2023-08-01 10:22:44 -0500 | Rating Details | |
2023-08-01 10:14:19 -0500 | Rating Details | |
2023-08-01 10:13:04 -0500 | Rating Details | |
2023-08-01 10:09:39 -0500 | Rating Details | |
2023-08-01 10:05:11 -0500 | Rating Details | |
2023-08-01 10:00:42 -0500 | Rating Details | |
2023-08-01 09:56:53 -0500 | Rating Details | |
2023-08-01 09:54:00 -0500 | Rating Details | |
2023-08-01 09:51:59 -0500 | Rating Details | |
2023-08-01 09:50:35 -0500 | Rating Details | |
2023-08-01 09:43:22 -0500 | Rating Details | |
2023-08-01 09:40:44 -0500 | Rating Details | |
2023-08-02 17:55:21 -0500 | Rating Details | |
2023-08-02 14:15:59 -0500 | Rating Details | |
2023-08-02 11:36:53 -0500 | Rating Details | |
2023-08-02 11:21:37 -0500 | Rating Details | |
2023-08-02 09:33:12 -0500 | Rating Details | |
2023-08-02 09:19:50 -0500 | Rating Details | |
2023-08-02 09:08:18 -0500 | Rating Details | |
2023-08-02 09:01:16 -0500 | Rating Details | |
2023-08-02 07:39:18 -0500 | Rating Details | |
2023-08-02 07:33:40 -0500 | Rating Details | |
2023-08-02 07:17:47 -0500 | Rating Details | |
2023-08-02 05:49:19 -0500 | Rating Details | |
2023-08-02 05:43:24 -0500 | Rating Details | |
2023-08-02 05:06:40 -0500 | Rating Details | |
2023-08-02 03:27:46 -0500 | Rating Details | |
2023-08-02 03:14:46 -0500 | Rating Details | |
2023-08-02 00:54:14 -0500 | Rating Details | |
2023-08-02 00:04:43 -0500 | Rating Details | |
2023-08-01 23:37:42 -0500 | Rating Details | |
2023-08-01 23:25:15 -0500 | Rating Details | |
2023-08-01 23:23:53 -0500 | Rating Details | |
2023-08-01 23:18:41 -0500 | Rating Details | |
2023-08-01 23:13:28 -0500 | Rating Details | |
2023-08-01 22:29:04 -0500 | Rating Details | |
2023-08-01 21:45:32 -0500 | Rating Details | |
2023-08-01 21:14:57 -0500 | Rating Details | |
2023-08-01 21:02:06 -0500 | Rating Details | |
2023-08-03 11:30:25 -0500 | Rating Details | |
2023-08-03 03:40:25 -0500 | Rating Details | |
2023-08-04 01:13:06 -0500 | Rating Details | |
2023-08-07 22:47:15 -0500 | Rating Details | |
2024-01-14 04:38:52 -0600 | Rating Details |